C#C[C@]1(O)CCC2C3C(CC[C@@]21C)[C@@]1(C)CC[C@@H](O)CC1=C[C@H]3O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?